InvestorsHub Logo
icon url

cheynew

06/20/10 10:13 AM

#52088 RE: cjgaddy #52087

Have you asked management about the discrepancy? Wouldn't the chart at the poster session have the most current info since the abstracts have to be submitted much earlier?

Any thoughts/expectations on the upcoming financial info for y/e 4/30/10?
icon url

entdoc

06/20/10 11:09 AM

#52090 RE: cjgaddy #52087

cj, most common reason is "lost to follow-up." Amazing how many people drop out of trials or do not return for follow-up visits, and cannot be reached, yada.
icon url

sunstar

06/20/10 11:53 AM

#52093 RE: cjgaddy #52087

Mojojojo, I take your point and agree, the graph depicts the state of the greatest reduction. I also think we need to see that this degree of tumor reduction is truly remarkable.

It looks like another major attribute of bavi will be its ability to surge the immune system response to the cancer. As cjgaddy has noted, that a patient who has achieved a 100% tumor reduction during one RECIST measurement, and has a reading of 98% at a subsequent RECIST is considered to have progression. The patient may have a strong reduction in tumor size and doing well while still being considered to have progressed.

With so many strong responses to bavi I’m expecting overall survival to be high. This Overall Survival (OS) data will be revealing of the relationship between strong positive tumor reductions and long term survival.

sunstar